Jaebong Jang

Title: Jaebong Jang: Innovator in Bioconjugation

Introduction

Jaebong Jang is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of bioconjugation through his innovative research and patents. His work focuses on developing compounds that can selectively bind to specific amino acids, which has important implications in various scientific applications.

Latest Patents

Jaebong Jang holds a patent for a quinolinone derivative compound that selectively binds to cysteine. This patent, titled "Quinolinone derivative compound selectively binding to cysteine, peptide conjugate thereof, and antibody-drug conjugate comprising same," describes a method for creating a conjugate with high chemoselectivity and yield through a radical pathway induced by visible light. This innovative approach can be applied in various ways to enhance bioconjugation techniques.

Career Highlights

Throughout his career, Jaebong Jang has worked with esteemed institutions such as the Institute for Basic Science and the Korea Advanced Institute of Science and Technology. His research has contributed to advancements in the understanding and application of bioconjugation in scientific research.

Collaborations

Jaebong Jang has collaborated with notable colleagues, including Sungwoo Hong and Hangyeol Choi. These collaborations have further enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Jaebong Jang is a distinguished inventor whose work in bioconjugation has paved the way for new scientific advancements. His innovative patent and collaborations highlight his commitment to enhancing the field of biochemistry.